AU7105498A - Combination therapy for the prevention and treatment of osteoporosis - Google Patents

Combination therapy for the prevention and treatment of osteoporosis

Info

Publication number
AU7105498A
AU7105498A AU71054/98A AU7105498A AU7105498A AU 7105498 A AU7105498 A AU 7105498A AU 71054/98 A AU71054/98 A AU 71054/98A AU 7105498 A AU7105498 A AU 7105498A AU 7105498 A AU7105498 A AU 7105498A
Authority
AU
Australia
Prior art keywords
osteoporosis
prevention
treatment
combination therapy
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71054/98A
Inventor
Arthur A. Patchett
Gideon A Rodan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9716883.5A external-priority patent/GB9716883D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7105498A publication Critical patent/AU7105498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU71054/98A 1997-04-14 1998-04-09 Combination therapy for the prevention and treatment of osteoporosis Abandoned AU7105498A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4381597P 1997-04-14 1997-04-14
US60043815 1997-04-14
GBGB9716883.5A GB9716883D0 (en) 1997-08-08 1997-08-08 Combination therapy for the prevention and treatent of osteoporosis
GB9716883 1997-08-08
PCT/US1998/007065 WO1998046220A1 (en) 1997-04-14 1998-04-09 Combination therapy for the prevention and treatment of osteoporosis

Publications (1)

Publication Number Publication Date
AU7105498A true AU7105498A (en) 1998-11-11

Family

ID=26312043

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71054/98A Abandoned AU7105498A (en) 1997-04-14 1998-04-09 Combination therapy for the prevention and treatment of osteoporosis

Country Status (2)

Country Link
AU (1) AU7105498A (en)
WO (1) WO1998046220A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU759449C (en) 1998-04-09 2003-10-30 Meiji Seika Pharma Co.,Ltd. Aminopiperidine derivatives as integrin alpha v beta 3 antagonists
AU6316900A (en) 1999-08-05 2001-03-05 Meiji Seika Kaisha Ltd. Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism
WO2002060894A2 (en) 2001-01-30 2002-08-08 Bristol-Myers Squibb Company Sulfonamide lactam inhibitors of factor xa
SI3929196T1 (en) 2013-09-24 2023-11-30 Fujifilm Corporation Pharmaceutical composition of a nitrogen-containing compound or salt thereof, or metal complex thereof
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
US11046685B2 (en) 2017-02-28 2021-06-29 Morphic Therapeutic, Inc. Inhibitors of (α-v)(β-6) integrin
SG11201907820SA (en) 2017-02-28 2019-09-27 Morphic Therapeutic Inc Inhibitors of (alpha-v)(beta-6) integrin
US20200071322A1 (en) 2018-08-29 2020-03-05 Morphic Therapeutic, Inc. Inhibiting (alpha-v)(beta-6) integrin
EP3843727A4 (en) * 2018-08-29 2022-08-17 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin
EP3843728A4 (en) * 2018-08-29 2022-05-25 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
DE4222301A1 (en) * 1992-07-08 1994-01-13 Basf Ag Homogeneous polymeric ammonium salt and its use
US5283241A (en) * 1992-08-28 1994-02-01 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
US5578593A (en) * 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
US5492916A (en) * 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
JPH10504807A (en) * 1994-06-29 1998-05-12 スミスクライン・ビーチャム・コーポレイション Vitronectin receptor antagonist
DE19504954A1 (en) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhesion receptor antagonists

Also Published As

Publication number Publication date
WO1998046220A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
AU4411297A (en) Combination therapy for treatment of psychoses
GB9407135D0 (en) Treatment of osteoporosis
PL328831A1 (en) Combined treatment of osteoporosis
AU3891299A (en) Combination therapy for treatment of depression
AU7449598A (en) Medicinal composition for prevention or treatment of hepatopathy
AU1139095A (en) Combination treatment for osteoporosis
AU7772794A (en) Treatment of obesity
AU2508597A (en) Drug for the treatment of tumours
AU6435398A (en) Prevention and treatment of hepatocellular cancer
GB9808936D0 (en) Combination therapy for the prevention and treatment of osteoporosis
AU1556497A (en) Agents for the treatment and prevention of aids
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
AU1497897A (en) Combination therapy to treat osteoporosis
AU2476200A (en) Ribozyme therapy for the treatment and/or prevention of restenosis
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
AU7484596A (en) Combination therapy for the treatment of diabetes and obesity
AU2870597A (en) Treatment of liquid
AU5558498A (en) Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
HUP0100365A3 (en) Combination therapy for the treatment of aids
EP0981545A4 (en) Treatment of osteoporosis
AU1940800A (en) Combination therapy for the treatment of sepsis
EP0969852A4 (en) Combination therapy for the treatment of diabetes and obesity
EP0733365A3 (en) Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
AU4107797A (en) Compounds for the treatment and prevention of diabetes
AU8809098A (en) Procedure and apparatus for the treatment of waste

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase